SBA
BIIB icon

Seven Bridges Advisors’s Biogen BIIB Stock Holding History

Seven Bridges Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-610
Closed -$194K – 18
2017
Q4 		$194K Hold
610
– – 0.16% 97
2017
Q3 		$191K Sell
610
-1,234
-67% -$365K 0.16% 106
2017
Q2 		$500K Sell
1,844
-492
-21% -$130K 0.45% 62
2017
Q1 		$639K Buy
2,336
+86
+4% +$24.3K 0.61% 52
2016
Q4 		$638K Sell
2,250
-170
-7% -$50.4K 0.65% 44
2016
Q3 		$758K Buy
2,420
+1,174
+94% +$348K 0.67% 43
2016
Q2 		$301K Sell
1,246
-156
-11% -$41.1K 0.26% 86
2016
Q1 		$365K Sell
1,402
-352
-20% -$93K 0.29% 81
2015
Q4 		$537K Buy
+1,754
New +$504K 0.54% 60

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Seven Bridges Advisors's BIIB Position: Q1 2018 in Review

Seven Bridges Advisors sold out of Biogen (BIIB) in Q1 2018, closing a stake of 610 shares — an estimated $194K sold.

Seven Bridges Advisors first reported a position in BIIB in Q4 2015 and held it in 9 quarters. The position peaked at $758K in Q3 2016. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Seven Bridges Advisors reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Seven Bridges Advisors sold 610 Biogen shares in Q1 2018, an estimated $194K.
  • Seven Bridges Advisors first reported a position in Biogen in Q4 2015 and held it in 9 quarters.
  • Seven Bridges Advisors's Biogen position peaked at $758K in Q3 2016.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Seven Bridges Advisors's 13F filing for Q1 2018, filed 9 May 2018.